0512-80988088
当前位置:首页 >产品中心 >定量POCT产品 >心脏疾病诊断 心脏疾病诊断

MYO Quantitative Test Kit

Time-Resolved Fluorescent Immunochromatographic Assay

【General Information】

1.Method: Time-resolved Fluorescent Immunochromatographic Method;

2.Bio-marker tested: myoblobin (MYO)  ;

3.Clinical Sample: whole blood,  serum or plasma;

4.Other Specifications: in vitro, quantitative test;

【Clinical significance】

1. As myocardial infarction (AMI) early detection indicators, highly sensitive;

2. Peaked 1-3h after the onset;

3. Diagnose reinfarction or infarct extension;

4. Determine myocardial re-perfusion.

【Advantages】

1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography;

2. Quantitative: quantitative detection of myocardial infarction marker myoblobin (MYO);

3. Accurate: well correlated with imported chemiluminescence reagent (r> 0.975) ;

4. High sensitivity: lower detection limit <1.0 ng/mL ;

5. Simple: simple operation, suitable for bedside detection;

6. Widely applicable : outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc;




返回顶部

更早
2016年02月

手持仪器PocRoc 2S获得注册证

2015年10月

再获5个生化项目注册证,光景生化项目达到10项!

2015年07月

获得CE认证

2014年04月

获得4个即时诊断(POCT)产品注册证书

2014年03月

获得5个纳米微球增强生化产品注册证书

2014年02月

获得时间分辨荧光免疫分析仪产品注册证书

2014年01月

何爱民博士入选“国家千人计划创业人才”